Non-conventional imaging of lung cancer.
This presentation discusses the optimum magnetic resonance imaging (MRI) sequence for lung cancer assessment in a clinical setting, and the sensitivity and specificity of MRI (alone and in combination with diffusion-weighted imaging (DWI)-MR) compared with those of computed tomography (CT) and fluorodeoxyglucose-positron emission tomography (PET) for lung cancer staging. The role of perfusion studies (by CT or MRI), of DWI-MRI, blood oxygenation level dependent sequences and PET in defining the aggressiveness of lung tumours and in evaluating the response to radiochemotherapy is also discussed.
Bellomi
M
M
European Institute of Oncology, Via Ripamonti 435, Milan, Italy.
D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods